Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+10.4%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$13.3B
AUM Growth
+$13.3B
(+80,795%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
2,413
New
102
Increased
498
Reduced
1,008
Closed
275
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$297M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$295M |
| 3 |
NVIDIA
NVDA
|
+$51.8M |
| 4 |
NetEase
NTES
|
+$51.7M |
| 5 |
JD.com
JD
|
+$44.9M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$41.5M |
| 2 |
Microsoft
MSFT
|
+$38.6M |
| 3 |
Nike
NKE
|
+$29.7M |
| 4 |
Visa
V
|
+$21.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$16.7M |
Sector Composition
| 1 | Technology | 19.04% |
| 2 | Healthcare | 12.16% |
| 3 | Financials | 11.34% |
| 4 | Communication Services | 9.82% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Adeia
ADEA
$1.71B
| $170K | ﹤0.01% |
38,008
| – | – |
|
1327
Houlihan Lokey
HLI
$14.1B
| $170K | ﹤0.01% |
1,600
| – | – |
|
1328
Douglas Elliman
DOUG
$230M
| $169K | ﹤0.01% |
+22,917
| New | +$169K |
|
1329
8x8 Inc
EGHT
$285M
| $169K | ﹤0.01% |
11,040
-5,860
| -35% | -$89.7K |
|
1330
NovoCure
NVCR
$1.37B
| $169K | ﹤0.01% |
2,460
-1,258
| -34% | -$86.4K |
|
1331
Portland General Electric
POR
$4.65B
| $168K | ﹤0.01% |
3,200
| – | – |
|
1332
Kelly Services Class A
KELYA
$465M
| $166K | ﹤0.01% |
9,700
| – | – |
|
1333
Novanta
NOVT
$4.14B
| $166K | ﹤0.01% |
1,205
-150
| -11% | -$20.7K |
|
|
SASR
1334
DELISTED
Sandy Spring Bancorp Inc
SASR
| $166K | ﹤0.01% |
3,500
-600
| -15% | -$28.5K |
|
|
EAR
1335
DELISTED
Eargo, Inc. Common Stock
EAR
| $165K | ﹤0.01% |
+1,715
| New | +$165K |
|
1336
Brookfield Infrastructure
BIPC
$4.78B
| $164K | ﹤0.01% |
3,705
+1,680
| +83% | +$74.4K |
|
1337
Essent Group
ESNT
$6.24B
| $163K | ﹤0.01% |
3,565
-680
| -16% | -$31.1K |
|
1338
Innospec
IOSP
$2.06B
| $163K | ﹤0.01% |
1,750
-550
| -24% | -$51.2K |
|
1339
Qualys
QLYS
$4.75B
| $163K | ﹤0.01% |
1,275
+350
| +38% | +$44.7K |
|
1340
Central Pacific Financial
CPF
$834M
| $162K | ﹤0.01% |
5,570
+600
| +12% | +$17.5K |
|
|
CVET
1341
DELISTED
Covetrus, Inc. Common Stock
CVET
| $162K | ﹤0.01% |
8,980
-600
| -6% | -$10.8K |
|
1342
Euronet Worldwide
EEFT
$3.57B
| $161K | ﹤0.01% |
1,200
| – | – |
|
1343
Simply Good Foods
SMPL
$2.78B
| $161K | ﹤0.01% |
4,580
+160
| +4% | +$5.62K |
|
1344
Merit Medical Systems
MMSI
$5.34B
| $160K | ﹤0.01% |
2,890
+90
| +3% | +$4.98K |
|
1345
Sarepta Therapeutics
SRPT
$1.87B
| $160K | ﹤0.01% |
2,231
-850
| -28% | -$61K |
|
1346
SS&C Technologies
SSNC
$21.6B
| $160K | ﹤0.01% |
2,000
+600
| +43% | +$48K |
|
|
MDRX
1347
DELISTED
Veradigm Inc. Common Stock
MDRX
| $160K | ﹤0.01% |
7,910
+80
| +1% | +$1.62K |
|
1348
Herc Holdings
HRI
$4.43B
| $159K | ﹤0.01% |
990
-300
| -23% | -$48.2K |
|
1349
John B. Sanfilippo & Son
JBSS
$724M
| $158K | ﹤0.01% |
2,000
-3,800
| -66% | -$300K |
|
1350
Insight Enterprises
NSIT
$4.07B
| $157K | ﹤0.01% |
1,670
| – | – |
|